Cargando…

Serum Free Light Chain Assay as a Prognostic Marker in Patients with Aggressive B-Cell Non-Hodgkin's Lymphoma: Impact on Survival Outcome

Background The role of serum free light chain (FLC) as a prognostic biomarker in lymphoproliferative diseases is being increasingly studied. In this study we present the 5-year survival outcome for patients with aggressive B-cell non-Hodgkin's lymphoma (NHL) and their relation to FLC and other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anoop, T.M., Narayanan, Geetha, Chacko, Steffi, Krishna, K.M. Jagathnath, Nair, Sreejith G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803539/ https://www.ncbi.nlm.nih.gov/pubmed/36588611 http://dx.doi.org/10.1055/s-0042-1743426

Ejemplares similares

Early Normalization of Free Light Chains Predicts Better Outcomes in Patients with Multiple Myeloma
por: Benson, Rony, et al.
Publicado: (2020)

All-trans-retinoic acid–induced pseudotumor cerebri in acute promyelocytic leukemia
por: Anoop, T. M., et al.
Publicado: (2014)

Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016)

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
por: Zhou, Minglong, et al.
Publicado: (2008)

Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia
por: Krishna Chandran, Ramachandran, et al.
Publicado: (2019)

Analytical and clinical concordance of free light chain assay
por: Smith, Andrew, et al.
Publicado: (2018)

Flow cytometric light chain analysis of peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.
por: Johnson, A., et al.
Publicado: (1985)

Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Alessa, Mohammed A., et al.
Publicado: (2015)

Extranodal large B-cell type aggressive non-Hodgkin's lymphoma
por: Batra, Ranmeet, et al.
Publicado: (2014)

Aggressive squamous cell carcinoma as a harbinger of non-Hodgkin lymphoma
por: Callaghan, Daniel J., et al.
Publicado: (2018)

Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myeloma
por: Willrich, Maria Alice V., et al.
Publicado: (2022)

Rituximab induced hypoglycemia in non-Hodgkin's lymphoma
por: Hussain, Badrudeen M, et al.
Publicado: (2006)

Silver Nanoparticle-Based Assay for the Detection of Immunoglobulin Free Light Chains
por: Lizoń, Anna, et al.
Publicado: (2019)

Verification study of free light chains assays on reagent-optimized analysers
por: Šegulja, Dragana, et al.
Publicado: (2019)

Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients
por: Sprangers, Ben, et al.
Publicado: (2020)

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma
por: Kang, Ka-Won, et al.
Publicado: (2018)

Epidemiology of Non-Hodgkin’s Lymphoma
por: Thandra, Krishna C., et al.
Publicado: (2021)

Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
por: Camus, Vincent, et al.
Publicado: (2021)

Tobacco and Alcohol Use and the Impact of School Based Antitobacco Education for Knowledge Enhancement among Adolescent Students of Rural Kerala, India
por: Jayakrishnan, Radhakrishnan, et al.
Publicado: (2016)

Effectiveness of School based Awareness Programmes against Tobacco among Users and Non- Users– A Cross- Sectional Study from Rural Kerala, India
por: Jayakrishnan, Radhakrishnan, et al.
Publicado: (2019)

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?
por: Hackshaw, A, et al.
Publicado: (2004)

Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
por: Johnson, P. W., et al.
Publicado: (1993)

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy
por: Schmitz, Christine, et al.
Publicado: (2020)

Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin’s Lymphomas
por: Ramadan, Safaa, et al.
Publicado: (2021)

The Benefit of Telemonitoring in the Prevention of Septic Shock in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Dudová, Lucie, et al.
Publicado: (2023)

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
por: Lynch, Ryan C., et al.
Publicado: (2022)

Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B(5b )(CYB5B)
por: Murphy, Derek, et al.
Publicado: (2010)

Preoperative incremental shuttle walk test for morbidity and mortality prediction in elective major colorectal surgery
por: Soumya, CN, et al.
Publicado: (2022)

CD163 and c-Met expression in the lymph node and the correlations between elevated levels of serum free light chain and the different clinicopathological parameters of advanced classical Hodgkin's lymphoma
por: Bedewy, Magdy, et al.
Publicado: (2013)

Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas
por: Volpetti, Stefano, et al.
Publicado: (2014)

Aggressive extranodal peripheral T-cell non-Hodgkin's lymphoma: A rare case report and review
por: Bagirath, Pacha Venkat, et al.
Publicado: (2014)

CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi
por: Gopal, Satish, et al.
Publicado: (2016)

Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma
por: Zhong, Huijuan, et al.
Publicado: (2019)

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas
por: Witte, Hanno Maximilian, et al.
Publicado: (2023)

The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin’s lymphoma
por: Kadry, Dalia Y, et al.
Publicado: (2023)

Role of preoperative investigations in elderly patients undergoing oncosurgical procedures – A retrospective review audit
por: Ramesh, Bhagyalakshmi, et al.
Publicado: (2018)

CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin’s and aggressive non-hodgkin’s lymphomas
por: Ganeshan, B., et al.
Publicado: (2016)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report
por: Kandel, Devraj, et al.
Publicado: (2023)

Histiocytic Sarcoma: Clinical Features and Outcomes of Patients Treated at a Tertiary Cancer Care Center
por: Susan Joy Philip, Deepa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hlcmepsfhqihfougptqapogc4f